New Zealand Passes Milestone E-cigarette Legislation

Oct.27.2022
New Zealand Passes Milestone E-cigarette Legislation
New Zealand's landmark e-cigarette legislation bans sales to under 18s and restricts use in public spaces.

On November 11, 2020, the "2020 Smokefree Environments and Regulated Products (Vaping) Amendment Act" came into effect in New Zealand. Two years later, New Zealand passed a landmark vaping legislation.


New Zealand's legislation and regulations may not be perfect, but they continue to set an example for other countries eager to combat tobacco. It's not the time to throw the baby out with the bathwater," said Nancy Lucas, co-founder of the New Zealand Vaping Advocacy Alliance.


The bill aims to ensure that smokers who want to switch to safer alternatives can use e-cigarette products and also ensure that these products are not sold or distributed to minors. It seeks to strike a balance between promoting the use of e-cigarettes for harm reduction and preventing their use among young people.


Ms. Lucas stated that while New Zealand continues to implement various industry regulations, the requirements that went into immediate effect two years ago have had a positive impact.


Starting from November 11th, 2020, the use of electronic cigarettes is prohibited in workplaces, schools, childcare centers, and other locations. Sales of electronic cigarette products to individuals under the age of 18, as well as all advertising and sponsorships related to electronic cigarette products, are also prohibited. "If youth e-cigarette use is a problem, the solution isn't changing the law, because it's already abundant. The solution lies in parental responsibility and greater enforcement by regulatory agencies. Those found selling e-cigarettes to minors may face severe penalties. Any rogue retailer now has to face the consequences, as they make good legislation look bad," Ms. Lucas said.


The New Zealand E-Cigarette Advocacy Group has stated that the title of the Ministry of Health's website on e-cigarettes being "less harmful than smoking" is also world-leading.


New Zealand is currently engaged in a public battle to achieve a smoke-free status by 2025, which would mean reducing smoking rates to 5% or below. In comparison, Australia's ban on selling safer nicotine products and scaremongering tactics with publicly-funded campaigns have had little impact in reducing smoking rates in recent years, according to a spokesperson. In order to further curb the appeal and availability of deadly tobacco, the Health Select Committee will deliver a report on amendments to create smoke-free environments and regulated products, including traditional tobacco, by December 1st.


Ms. Lucas stated that now is the time for a strict crackdown on tobacco, rather than re-prosecuting the electronic cigarette rules and regulations that were fiercely debated and scrutinized by parliament and health leaders. "Governments, politicians, and officials from around the world continue to study the work that New Zealand has done in reducing smoking rates and achieving a smoke-free goal. Maintaining its harm reduction approach to tobacco is how New Zealand will suppress tobacco and save thousands of lives each year," said Nancy Lucas.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's contents. The compilation of this article is intended solely for industry exchange and research.


Due to limitations in translation proficiency, the translated article may not fully express the content of the original piece. Please refer to the original article for accuracy.


2FIRSTS is in complete alignment with the Chinese government when it comes to any domestic, Hong Kong, Macau and Taiwan-related, or foreign positions and expressions.


The copyright of the compiled information belongs to the original media and author. If there is infringement, please contact us to request removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22